Osteochondral lesions of the talus (OLTs) are an increasingly implicated cause of ankle pain and instability. Several treatment methods exist with varying clinical outcomes. Due in part to successful osteochondral allografting (OCA) in other joints, such as the knee and shoulder, OCA has gained popularity as a treatment option, especially in the setting of large lesions. The clinical outcomes of talar OCA have been inconsistent relative to the positive results observed in other joints. Current literature regarding OCA failure focuses mainly on 3 factors: the effect of graft storage conditions on chondrocyte viability, graft/lesion size, and operative technique. Several preclinical studies have demonstrated the ability for bone and cartilage tissue to invoke an immune response, and a limited number of clinical studies have suggested that this response may have the potential to influence outcomes after transplantation. Further research is warranted to investigate the role of immunological mechanisms as an etiology of OCA failure.
AdamsSBJrViensNAEasleyME. Midterm results of osteochondral lesions of the talar shoulder treated with fresh osteochondral allograft transplantation. J Bone Jt Surg Am. 2011;93(7):648-654.
2.
AllenRTRobertsonCMPennockAT. Analysis of stored osteochondral allografts at the time of surgical implantation. Am J Sports Med. 2005;33(10):1479-1484.
3.
AngthongCYoshimuraIKanazawaK. Critical three-dimensional factors affecting outcome in osteochondral lesion of the talus. Knee Surg Sports Traumatol Arthrosc. 2013;21(6):1418-1426.
4.
AssenmacherATPareekAReardonPJMacalenaJAStuartMJKrychAJ. Long-term outcomes after osteochondral allograft: a systematic review at long-term follow-up of 12.3 Years. Arthroscopy. 2016;32(10):2160-2168.
5.
BaeJYMatsumuraKWakitaniSKawaguchiATsutsumiSHyonSH.Beneficial storage effects of epigallocatechin-3-o-gallate on the articular cartilage of rabbit osteochondral allografts. Cell Transplantation. 2009;18(5):505-512.
6.
BalBSRahamanMNJayabalanP. In vivo outcomes of tissue-engineered osteochondral grafts. J Biomed Mater Res Part B Appl Biomater. 2010;93(1):164-174.
7.
BelfrageOIsakssonHTägilM.Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation: a bone chamber study in rats. BMC Musculoskelet Disord. 2012;13(1):240.
BianLStokerAMMarberryKMAteshianGACookJLHungCT.Effects of dexamethasone on the functional properties of cartilage explants during long-term culture. Am J Sports Med. 2010;38(1):78-85.
10.
BisicchiaSRossoFAmendolaA.Osteochondral allograft of the talus. Iowa Orthop J. 2014;34:30-37.
11.
BonfiglioMJeterWSSmithCL.The immune concept: its relation to bone transplantation. Ann N Y Acad Sci. 1955;59(3):417-433.
12.
BriggsDTSadrKNPulidoPABugbeeWD.The use of osteochondral allograft transplantation for primary treatment of cartilage lesions in the knee. Cartilage. 2015;6(4):203-207.
13.
BrooksDBHeipleKGHerndonCHPowellAE.Immunological factors in homogenous bone transplantation, IV: the effect of various methods of preparation and irradiation on antigenicity. J Bone Jt Surg Am. 1963;45:1617-1626.
14.
BugbeeWDKhannaGCavalloMMcCauleyJCGortzSBrageME.Bipolar fresh osteochondral allografting of the tibiotalar joint. J Bone Jt Surg Am. 2013;95(5):426-432.
15.
BugbeeWDPallante-KichuraALGortzSAmielDSahR.Osteochondral allograft transplantation in cartilage repair: graft storage paradigm, translational models, and clinical applications. J Orthop Res. 2016;34(1):31-38.
16.
BurwellRG.Studies in the transplantation of bone, V: the capacity of fresh and treated homografts of bone to evoke transplantation immunity. J Bone Jt Surg Br. 1963;45:386-401.
17.
BurwellRG.Studies of the primary and the secondary immune responses of lymph nodes draining homografts of fresh cancellous bone (with particular reference to mechanisms of lymph node reactivity). Ann N Y Acad Sci. 1962;99:821-860.
18.
BurwellRGGowlandGDexterF.Studies in the transplantation of bone, VI: further observations concerning the antigenicity of homologous cortical and cancellous bone. J Bone Jt Surg Br. 1963;45:597-608.
19.
CampbellCJRanawatCS.Osteochondritis dissecans: the question of etiology. J Trauma. 1966;6(2):201-221.
20.
ChalmersJ.Transplantation immunity in bone homografting. J Bone Jt Surg Br. 1959;41(1):160-179.
21.
ChangCHKuoTFLinCC. Tissue engineering-based cartilage repair with allogenous chondrocytes and gelatin-chondroitin-hyaluronan tri-copolymer scaffold: a porcine model assessed at 18, 24, and 36 weeks. Biomaterials. 2006;27(9):1876-1888.
22.
ChoiWJParkKKKimBSLeeJW.Osteochondral lesion of the talus: is there a critical defect size for poor outcome?Am J Sports Med. 2009;37(10):1974-1980.
23.
ChristensenJCDriscollHLTencerAF. 1994 William J. Stickel Gold Award. Contact characteristics of the ankle joint. Part 2. The effects of talar dome cartilage defects. J Am Podiatr Assoc. 1994;84(11):537-547.
24.
ChuckpaiwongBBerksonEMTheodoreGH.Microfracture for osteochondral lesions of the ankle: outcome analysis and outcome predictors of 105 cases. Arthroscopy. 2008;24(1):106-112.
25.
CookJLStokerAMStannardJP. A novel system improves preservation of osteochondral allografts. Clin Orthop Relat Res. 2014;472(11):3404-3414.
26.
CutticaDJSmithWBHyerCFPhilbinTMBerletGC.Osteochondral lesions of the talus: predictors of clinical outcome. Foot Ankle Int. 2011;32(11):1045-1051.
27.
DontchosBNCoyleCHIzzoNJ. Optimizing CO2 normalizes pH and enhances chondrocyte viability during cold storage. J Orthop Res. 2008;26(5):643-650.
28.
El-RashidyHVillacisDOmarIKelikianAS.Fresh osteochondral allograft for the treatment of cartilage defects of the talus: a retrospective review. J Bone Jt Surg Am. 2011;93(17):1634-1640.
29.
ElvesMW.Humoral immune response to allografts of bone. Int Arch Allergy Appl Immunol. 1974;47(5):708-715.
30.
FishmanJAGreenwaldMAGrossiPA.Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis. 2012;55(5):720-727.
31.
FriedlaenderGE.Immune responses to osteochondral allografts: current knowledge and future directions. Clin Orthop Relat Res. 1983;174:58-68.
32.
FriedlaenderGEStrongDMTomfordWWMankinHJ.Long-term follow-up of patients with osteochondral allografts: a correlation between immunologic responses and clinical outcome. Orthop Clin North Am. 1999;30(4):583-588.
33.
GaoJDennisJESolchagaLAAwadallahASGoldbergVMCaplanAI.Tissue-engineered fabrication of an osteochondral composite graft using rat bone marrow-derived mesenchymal stem cells. Tissue Eng. 2001;7(4):363-371.
34.
GaoJDennisJESolchagaLAGoldbergVMCaplanAI.Repair of osteochondral defect with tissue-engineered two-phase composite material of injectable calcium phosphate and hyaluronan sponge. Tissue Eng. 2002;8(5):827-837.
35.
GianniniSBudaRCavalloM. Bipolar fresh total osteochondral allograft: why, where, when: AAOS exhibit selection. J Bone Jt Surg Am. 2014;96(8):e65.
36.
GianniniSBudaRGrigoloB. Bipolar fresh osteochondral allograft of the ankle. Foot Ankle Int. 2010;31(1):38-46.
37.
GianniniSVanniniF.Operative treatment of osteochondral lesions of the talar dome: current concepts review. Foot Ankle Int. 2004;25(3):168-175.
38.
GobbiAFranciscoRALubowitzJHAllegraFCanataG.Osteochondral lesions of the talus: randomized controlled trial comparing chondroplasty, microfracture, and osteochondral autograft transplantation. Arthroscopy. 2006;22(10):1085-1092.
39.
GoldstoneRAPisaniAJ.Osteochondritis dissecans of the talus. N Y State J Med. 1965;65(19):2487-2494.
40.
GrossAEAgnidisZHutchisonCR.Osteochondral defects of the talus treated with fresh osteochondral allograft transplantation. Foot Ankle Int. 2001;22(5):385-391.
41.
GrossCEAdamsSBEasleyMENunleyJAII. Role of fresh osteochondral allografts for large talar osteochondral lesions. J Am Acad Orthop Surg. 2016;24(1):e9-e17.
42.
GuoXWangCDuanC. Repair of osteochondral defects with autologous chondrocytes seeded onto bioceramic scaffold in sheep. Tissue Eng. 2004;10(11-12):1830-1840.
43.
HaeneRQamiraniEStoryRAPinskerEDanielsTR.Intermediate outcomes of fresh talar osteochondral allografts for treatment of large osteochondral lesions of the talus. J Bone Jt Surg Am. 2012;94(12):1105-1110.
44.
HeipleKGChaseSWHerndonCH.A comparative study of the healing process following different types of bone transplantation. J Bone Jt Surg Am. 1963;45:1593-1616.
45.
HintermannBRegazzoniPLampertCStutzGGachterA.Arthroscopic findings in acute fractures of the ankle. J Bone Jt Surg Br. 2000;82(3):345-351.
46.
HuntHESadrKDeYoungAJGortzSBugbeeWD.The role of immunologic response in fresh osteochondral allografting of the knee. Am J Sports Med. 2014;42(4):886-891.
47.
JengCLKadakiaAWhiteKL. Fresh osteochondral total ankle allograft transplantation for the treatment of ankle arthritis. Foot Ankle Int. 2008;29(6):554-560.
48.
JudasFRosaSTeixeiraLLopesCFerreira MendesA.Chondrocyte viability in fresh and frozen large human osteochondral allografts: effect of cryoprotective agents. Transplantation Proc. 2007;39(8):2531-2534.
49.
KhanarianNTHaneyNMBurgaRALuHH.A functional agarose-hydroxyapatite scaffold for osteochondral interface regeneration. Biomaterials. 2012;33(21):5247-5258.
50.
Kossowska-PaulB.Studies on the regional lymph node blastic reaction evoked by allogeneic grafts of fresh and preserved bone tissue. Bull Acad Pol Sci Biol. 1966;14(9):651-657.
51.
KreuzFPHyattGWTurnerTCBassettAL.The preservation and clinical use of freeze-dried bone. J Bone Jt Surg Am. 1951;33(4):863-872.
52.
LangerFGrossAE.Immunogenicity of allograft articular cartilage. J Bone Jt Surg. 1974;56(2):297-304.
53.
LattLDGlissonRRMontijoHEUsuelliFGEasleyME.Effect of graft height mismatch on contact pressures with osteochondral grafting of the talus. Am J Sports Med. 2011;39(12):2662-2669.
54.
LeumannAHorisbergerMBuettnerOMueller-GerblMValderrabanoV.Medial malleolar osteotomy for the treatment of talar osteochondral lesions: anatomical and morbidity considerations. Knee Surg Sports Traumatol Arthrosc. 2016;24(7):2133-2139.
LinnMSChaseDCHealeyRMHarwoodFLBugbeeWDAmielD.Etanercept enhances preservation of osteochondral allograft viability. Am J Sports Med. 2011;39(7):1494-1499.
58.
LyonRNissenCLiuXCCurtinB.Can fresh osteochondral allografts restore function in juveniles with osteochondritis dissecans of the knee?Clin Orthop Relat Res. 2013;471(4):1166-1173.
59.
MalininTTempleHTBuckBE.Transplantation of osteochondral allografts after cold storage. J Bone Jt Surg Am. 2006;88(4):762-770.
60.
MasuokaKAsazumaTHattoriH. Tissue engineering of articular cartilage with autologous cultured adipose tissue-derived stromal cells using atelocollagen honeycomb-shaped scaffold with a membrane sealing in rabbits. J Biomed Mater Res Part B Appli Biomater. 2006;79(1):25-34.
61.
MauryACSafirOHerasFL. Twenty-five-year chondrocyte viability in fresh osteochondral allograft: a case report. J Bone Jt Surg Am. 2007;89(1):159-165.
62.
McCormickFHarrisJDAbramsGD. Trends in the surgical treatment of articular cartilage lesions in the United States: an analysis of a large private-payer database over a period of 8 years. Arthroscopy. 2014;30(2):222-226.
MickeviciusTPockeviciusAKucinskasA. Impact of storage conditions on electromechanical, histological, and histochemical properties of osteochondral allografts. BMC Musculoskelet Disord. 2015;16:314.
65.
MinDIMonacoAP.Complications associated with immunosuppressive therapy and their management. Pharmacotherapy. 1991;11(5):119S-125S.
66.
MubarakSJCarrollNC.Familial osteochondritis dissecans of the knee. Clin Orthop Relat Res. 1979;140:131-136.
67.
MurphyRTPennockATBugbeeWD.Osteochondral allograft transplantation of the knee in the pediatric and adolescent population. Am J Sports Med. 2014;42(3):635-640.
68.
O’LoughlinPFHeyworthBEKennedyJG.Current concepts in the diagnosis and treatment of osteochondral lesions of the ankle. Am J Sports Med. 2010;38(2):392-404.
PallanteALBaeWCChenACGortzSBugbeeWDSahRL.Chondrocyte viability is higher after prolonged storage at 37 degrees C than at 4 degrees C for osteochondral grafts. Am J Sports Med. 2009;37(suppl 1):24S-32S.
71.
PearsallAWMadanagopalSGHugheyJT.Osteoarticular autograft and allograft transplantation of the knee: 3 year follow-up. Orthopedics. 2008;31(1):73.
72.
PearsallAWtTuckerJAHesterRBHeitmanRJ. Chondrocyte viability in refrigerated osteochondral allografts used for transplantation within the knee. Am J Sports Med. 2004;32(1):125-131.
73.
PickMP.Familial osteochondritis dissecans. J Bone Jt Surg Br. 1955;37(1):142-145.
74.
PomajzlRJBakerEABakerKC. Case series with histopathologic and radiographic analyses following failure of fresh osteochondral allografts of the talus. Foot Ankle Int. 2016;37(9):958-967.
75.
QiJHuZSongH. Cartilage storage at 4 degrees C with regular culture medium replacement benefits chondrocyte viability of osteochondral grafts in vitro. Cell Tissue Banking. 2016;17(3):473-479.
76.
RazGSafirOABacksteinDJLeePTGrossAE.Distal femoral fresh osteochondral allografts: follow-up at a mean of twenty-two years. J Bone Jt Surg Am. 2014;96(13):1101-1107.
77.
RobertsNHughesR.Osteochondritis dissecans of the elbow joint, a clinical study. J Bone Jt Surg Br. 1950;32(3):348-360.
78.
RodenSTillegardPUnanderscharinL.Osteochondritis dissecans and similar lesions of the talus: report of fifty-five cases with special reference to etiology and treatment. Acta Orthop Scand. 1953;23(1):51-66.
79.
SadrKNPulidoPAMcCauleyJCBugbeeWD.Osteochondral allograft transplantation in patients with osteochondritis dissecans of the knee. Am J Sports Med. 2016;44(11):2870-2875.
80.
SayeghETMascarenhasRChalmersPNColeBJVermaNNRomeoAA.Allograft reconstruction for glenoid bone loss in glenohumeral instability: a systematic review. Arthroscopy. 2014;30(12):1642-1649.
81.
SchaeferDMartinIJundtG. Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum. 2002;46(9):2524-2534.
82.
SongHXLiFBShenHL. Repairing articular cartilage defects with tissue-engineering cartilage in rabbits. Chin J Traumatol. 2006;9(5):266-271.
83.
StevensonSDannucciGASharkeyNAPoolR.The fate of articular cartilage after transplantation of fresh and cryopreserved tissue-antigen-matched and mismatched osteochondral allografts in dogs. J Bone Jt Surg. 1989;71(9):1297-1307.
84.
StokerAGarrityJTHungCTStannardJPCookJ.Improved preservation of fresh osteochondral allografts for clinical use. J Knee Surg. 2012;25(2):117-125.
85.
StrongDMFriedlaenderGETomfordWW. Immunologic responses in human recipients of osseous and osteochondral allografts. Clin Orthop Relat Res. 1996;326:107-114.
86.
TolJLStruijsPABossuytPMVerhagenRAvan DijkCN.Treatment strategies in osteochondral defects of the talar dome: a systematic review. Foot Ankle Int. 2000;21(2):119-126.
TriceMEBugbeeWDGreenwaldASHeimCS.Articular Cartilage Restoration: A Review of Currently Available Methods. New Orleans, LA: American Academy of Orthopaedic Surgeons, Committee on Biological Implants, 2010.
90.
WilliamsRJIIIDreeseJCChenCT.Chondrocyte survival and material properties of hypothermically stored cartilage: an evaluation of tissue used for osteochondral allograft transplantation. Am J Sports Med. 2004;32(1):132-139.
91.
WilliamsSKAmielDBallST. Analysis of cartilage tissue on a cellular level in fresh osteochondral allograft retrievals. Am J Sports Med. 2007;35(12):2022-2032.
92.
YamadaTUchidaKOnumaK. Hyaluronic acid (800 kDa) supplementation of University of Wisconsin solution improves viability of osteochondral grafts and reduces matrix metalloproteinase expression during cold preservation. ScientificWorldJournal. 2015;2015:631369.
93.
YlänenHOHelminenTHelminenARantakokkoJKarlssonKHAroHT.Porous bioactive glass matrix in reconstruction of articular osteochondral defects. Ann Chir Gynaecol. 1999;88(3):237-245.
